Home/Filings/4/0001555667-15-000034
4//SEC Filing

SOLAZYME INC 4

Accession 0001555667-15-000034

CIK 0001311230operating

Filed

Mar 10, 8:00 PM ET

Accepted

Mar 11, 4:38 PM ET

Size

5.2 KB

Accession

0001555667-15-000034

Insider Transaction Report

Form 4
Period: 2015-03-09
Painter Tyler
Chief Financial Officer
Transactions
  • Sale

    Common Stock

    2015-03-09$2.69/sh19,062$51,368407,000 total
Footnotes (2)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan and were mainly to cover tax withholding obligations in connection with the vesting of restricted stock units that occurred on or shortly before the date of sale.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.5657 to $2.79, inclusive. The reporting person undertakes to provide to Solazyme, Inc., any security holder of Solazyme, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Issuer

SOLAZYME INC

CIK 0001311230

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001311230

Filing Metadata

Form type
4
Filed
Mar 10, 8:00 PM ET
Accepted
Mar 11, 4:38 PM ET
Size
5.2 KB